Literature DB >> 28903611

Maternal leukocytosis after antenatal corticosteroid administration: a systematic review and meta-analysis.

Melissa E Bauer1, Laura K Price2, Mark P MacEachern3, Michelle Housey1, Elizabeth S Langen4, Samuel T Bauer2.   

Abstract

Although it is known that corticosteroid administration causes leukocytosis, the magnitude and length of time this leukocytosis persists is unknown during pregnancy. This study aimed to establish the expected range of maternal leukocytosis in healthy pregnant women at risk for preterm delivery after antenatal corticosteroid administration. PubMed, Embase and ClinicalTrials.gov were searched to identify the studies in healthy women at risk for preterm delivery without signs of clinical infection that reported white blood cell values preceding and after antenatal corticosteroid administration. The inverse variance weighting technique was used to calculate the weighted means and the standard deviation from the mean for each time period. Six studies met inclusion criteria and included 524 patients and 1406 observations. Mean ± standard deviation maternal white blood cell count values prior to antenatal corticosteroid administration and up to 24, 48, 72 and 96 hours after corticosteroid administration were 10.4 ± 2.4, 13.6 ± 3.6, 12.1 ± 3.0, 11.5 ± 2.9 and 11.1 ± 2.5 × 109/L, respectively. Leukocytosis in healthy, non-infected women is expected to peak 24 hours after antenatal corticosteroid administration and the magnitude of increase is small. Impact statement What is already known on this subject: While it is well known that administration of antenatal corticosteroids causes leukocytosis, it is currently unknown the magnitude and length of time the leukocytosis persists. What the results of this study add: This study establishes the expected range and the temporal progression and regression with antenatal corticosteroid administration in healthy pregnant women at risk for preterm delivery without clinical signs of infection. What the implications are of these findings for clinical practice and/or further research: Clinicians may wish to consider further investigation into the clinical cause, whether infectious or non-infectious, for absolute values and changes outside this range.

Entities:  

Keywords:  Prenatal care; corticosteroids; leukocyte count; leukocytosis; pregnancy; steroids

Mesh:

Substances:

Year:  2017        PMID: 28903611     DOI: 10.1080/01443615.2017.1342614

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  3 in total

1.  Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth.

Authors:  Anke C Rohwer; Olufemi T Oladapo; G Justus Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2020-05-26

2.  Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India.

Authors:  Alan H Jobe; Mark A Milad; Thomas Peppard; William J Jusko
Journal:  Clin Transl Sci       Date:  2019-12-13       Impact factor: 4.689

3.  Neutrophil-lymphocyte ratio for the prediction of histological chorioamnionitis in cases of preterm premature rupture of membranes: a case-control study.

Authors:  Greta Balciuniene; Greta Kvederaite-Budre; Violeta Gulbiniene; Irena Dumalakiene; Rita Viliene; Ingrida Pilypiene; Grazina S Drasutiene; Diana Ramasauskaite
Journal:  BMC Pregnancy Childbirth       Date:  2021-09-27       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.